Biological Rationale and Current Clinical Experience With Anti-Insulin-Like Growth Factor 1 Receptor Monoclonal Antibodies in Treating Sarcoma

Title
Biological Rationale and Current Clinical Experience With Anti-Insulin-Like Growth Factor 1 Receptor Monoclonal Antibodies in Treating Sarcoma
Authors
Keywords
-
Journal
CANCER JOURNAL
Volume 16, Issue 3, Pages 183-194
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2010-05-28
DOI
10.1097/ppo.0b013e3181dbebf9

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started